Matsuguma, Kyoko
11  results:
Search for persons X
?
2

BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study o..:

Sakamoto, Kei ; Matsuki, Shunji ; Matsuguma, Kyoko...
The Journal of Clinical Pharmacology.  57 (2017)  11 - p. 1460-1471 , 2017
 
?
5

A comparative pharmacokinetic and pharmacodynamic study of ..:

Matsuguma, Kyoko ; Matsuki, Shunji ; Sakamoto, Kei...
Clinical Pharmacology in Drug Development.  4 (2015)  2 - p. 99-104 , 2015
 
?
6

Evaluation of Assay Sensitivity and the Concentration-Effec..:

Shiramoto, Masanari ; Uchimaru, Hinako ; Kaji, Yoshikazu...
Therapeutic Innovation & Regulatory Science.  48 (2014)  2 - p. 181-189 , 2014
 
?
7

Brivaracetam Single and Multiple Rising Oral Dose Study in ..:

Stockis, Armel ; Watanabe, Shikiko ; Rouits, Elisabeth..
Drug Metabolism and Pharmacokinetics.  29 (2014)  5 - p. 394-399 , 2014
 
?
8

Mechanisms of Pharmacokinetic Enhancement Between Ritonavir..:

Ieiri, Ichiro ; Tsunemitsu, Shyohei ; Maeda, Kazuya...
The Journal of Clinical Pharmacology.  53 (2013)  6 - p. 654-661 , 2013
 
?
9

Pharmacogenomic/pharmacokinetic assessment of a four-probe ..:

Ieiri, Ichiro ; Fukae, Masato ; Maeda, Kazuya...
Int. Journal of Clinical Pharmacology and Therapeutics.  50 (2012)  10 - p. 689-700 , 2012
 
?
10

Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochl..:

Murakami, Makoto ; Furuie, Hidetoshi ; Matsuguma, Kyoko...
Drug Metabolism and Pharmacokinetics.  20 (2005)  5 - p. 337-344 , 2005
 
?
11

Recapitulation of Clinical Individual Susceptibility to Dru..:

Tadahiro Shinozawa ; Koki Nakamura ; Masanobu Shoji...
http://www.sciencedirect.com/science/article/pii/S2213671116303046.  , 2017
 
1-11